The Supreme Court intervened in the abortion medication debate this evening, allowing mifepristone to remain accessible through telemedicine and mail delivery nationwide. The decision blocks a lower court ruling that would have restricted access in states with abortion bans, maintaining current prescription protocols while litigation continues through the federal court system.

The justices' temporary order prevents significant disruption to abortion access in restrictive states. With medication accounting for over half of U.S. abortions, this ruling ensures continued availability during an ongoing legal battle that may last for months. The lower court's original decision would have required in-person visits for medication distribution, a particularly burdensome requirement in states with few abortion providers.

Conservative justices Clarence Thomas and Samuel Alito dissented from the decision, which represents a temporary victory for abortion rights advocates as the case works through the lower courts. The ruling does not resolve the underlying legal questions but provides immediate continuity in medication access for patients across the country.